Ardelyx, Inc. is a clinical-stage biopharmaceutical company. The Company's therapeutics focuses on addressing cardiorenal and gastrointestinal (GI) diseases. It operates through the research, development and commercialization of biopharmaceutical pro... Read more
MarketWatch
Yahoo
CNBC
Yahoo
Access detailed stock analysis from LSEG including analyst price target estimates.